| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/10/2005 | EP1560574A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin |
| 08/10/2005 | CN1653073A Substituted phenylacetic acids |
| 08/10/2005 | CN1653051A Substituted anthranilamides for controlling invertebrate pests |
| 08/10/2005 | CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 08/10/2005 | CN1653045A 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 08/10/2005 | CN1653043A Method for the production of sulphamic acid halogenides |
| 08/10/2005 | CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 08/10/2005 | CN1653040A HIF hydroxylase inhibitors |
| 08/10/2005 | CN1653037A Substituted tetracycline compounds |
| 08/10/2005 | CN1653025A NK1 antagonists |
| 08/10/2005 | CN1652779A Treatment of chemokine mediated diseases |
| 08/10/2005 | CN1651410A Preparation method of (S)-alpha-ethyl-2-keto-1-pyrrolidine acetamide |
| 08/10/2005 | CN1651392A 2-and 2, 5-substituted phenylketoenols |
| 08/10/2005 | CN1214040C Peptide derivatives having thiazolyl-alanine residue |
| 08/10/2005 | CN1213980C Vitamin D analogues |
| 08/09/2005 | US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation |
| 08/09/2005 | US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 08/09/2005 | US6927222 Compounds |
| 08/04/2005 | WO2005070919A1 N-type calcium channel blockers |
| 08/04/2005 | WO2005070884A2 Heterocyclic compounds useful as growth hormone secretagogues |
| 08/04/2005 | WO2005070877A1 Diamino alcohols and their use as renin inhibitors |
| 08/04/2005 | WO2005070876A1 METHOD OF ENANTHIO-SELECTIVE NUCLEOPHILIC ADDITION REACTION FOR CONVERSION OF ENAMIDE TO IMINE AND METHOD OF SYNTHESIZING α-AMINO-Ϝ-KETO ACID ESTER |
| 08/04/2005 | WO2005070864A1 METHOD OF ENANTIOMETRICALLY SELECTIVE NUCLEOPHILIC ADDITION REACTION TO CARBONYL OF ENAMIDE AND METHOD OF SYNTHESIZING OPTICALLY ACTIVE α-HYDROXY-Ϝ-KETO ACID ESTER AND HYDROXYDIKETONE |
| 08/04/2005 | WO2005058865A3 Assay for entactogens |
| 08/04/2005 | WO2005040355A3 Tao kinase modulators and methods of use |
| 08/04/2005 | WO2005037206A3 Anti-cancer compounds and methods of use thereof |
| 08/04/2005 | WO2005032464A3 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 08/04/2005 | US20050171357 Process for preparing indolinone derivatives |
| 08/04/2005 | US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/04/2005 | US20050171189 Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a mehtod for effective purification of racemic lasofoxifene |
| 08/04/2005 | US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/04/2005 | US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 08/04/2005 | US20050171181 Histamine-3 receptor modulators |
| 08/04/2005 | US20050171166 Use as inhibitors of FK560 binding proteins (FKBPs) enzyme activity for treating and preventing neurodegenerative diseases and other nerve disorders associated with nerve injury or other related diseases |
| 08/04/2005 | US20050171154 Carboxylic acid amides |
| 08/04/2005 | US20050171136 Modulators of the glucocorticoid receptor and method |
| 08/04/2005 | US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders |
| 08/04/2005 | US20050171102 Semicarbazide derivatives for combating thromboembolic diseases |
| 08/04/2005 | US20050171082 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 08/04/2005 | US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 08/04/2005 | CA2553831A1 Diamino alcohols and their use as renin inhibitors |
| 08/04/2005 | CA2553773A1 N-type calcium channel blockers |
| 08/03/2005 | EP1558613A2 Pre-organized tricyclic integrase inhibitor compounds |
| 08/03/2005 | EP1558594A2 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 08/03/2005 | EP1558567A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 08/03/2005 | EP1558566A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 08/03/2005 | EP1558253A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 08/03/2005 | EP1558246A1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 08/03/2005 | EP1305284A4 Process and intermediate compounds for the preparation of pyrrolidines |
| 08/03/2005 | EP1280527B1 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 08/03/2005 | CN1650163A Artificial receptors, building blocks, and methods |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/03/2005 | CN1649827A Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids |
| 08/03/2005 | CN1649583A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1213040C Serine protese inhibitors |
| 08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
| 08/03/2005 | CN1213027C Method for obtaining pure N-vinyl pyrrolidone |
| 08/03/2005 | CN1213026C Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/02/2005 | US6924396 α-haloenamine reagents |
| 08/02/2005 | US6924378 Method for production of aziridines and N-vinylamides |
| 08/02/2005 | US6924377 Etherifying mucochloric or mucobromic acid with an alcohol, alkylation, hydrogenation, dehydrochlorination or dehydrobromination, decyclization by reductive amination and carboxylation; 3-Aminomethyl-5-methyl-hexanoic acid |
| 08/02/2005 | US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 08/02/2005 | US6924286 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 08/02/2005 | US6923835 Hair dyes comprising heterocyclic amines such as N,N'-bis[1-(4-aminophenyl)pyrrolidin-3-yl]-N,N,N',N'-tetramethylhexane-1,6-diaminium dichloride having colorfastness and chemical resistance |
| 08/02/2005 | CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 08/02/2005 | CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities |
| 08/02/2005 | CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 07/28/2005 | WO2005068446A1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof |
| 07/28/2005 | WO2005068423A1 Malononitrile compound and use thereof |
| 07/28/2005 | US20050165242 hydrolysis of atorvastatin lactone with sodium hydroxide to form atorvastatin sodium salt solution; addition to an aqueous calcium chloride or calcium acetate solution; andisolation by filtration and drying; scalable, cost-effective and robust process |
| 07/28/2005 | US20050165228 Refined routes to chlorin building blocks |
| 07/28/2005 | US20050165114 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents; AP-1 activation inhibitor, NF-kappa B activation inhibitor |
| 07/28/2005 | US20050165084 Nitrate derivatives of atorvastatin with improved pharmacological activity and enhanced tolerability; treating coronary syndromes, neurodegenerative disorders, and for reducing cholesterol levels; antiinflammatory, antithrombotic and antiplatelet activity; atorvastatin 4-(nitrooxy)butyl ester |
| 07/28/2005 | US20050165065 N-type calcium channel blockers |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 07/28/2005 | US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides |
| 07/28/2005 | US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides |
| 07/28/2005 | DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 07/28/2005 | CA2552740A1 Indolylmaleimde derivatives as pkc inhibitors |
| 07/28/2005 | CA2552738A1 Indolylmaleimide derivatives |
| 07/28/2005 | CA2547696A1 Malononitrile compounds and use thereof |
| 07/28/2005 | CA2456430A1 Improved process for the preparation of amorphous atorvastatin calcium |
| 07/27/2005 | EP1557414A1 Isoquinoline compounds and medicinal use thereof |
| 07/27/2005 | EP1556390A2 Functionalized ionic liquids, and methods of use thereof |
| 07/27/2005 | EP1556385A1 Heterocyclocarboxamide derivatives |
| 07/27/2005 | EP1556376A1 Large conductance calcium-activated k channel opener |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556346A1 1-phenylpyrrolidine-2-one-3-carboxamides |
| 07/27/2005 | EP1556052A2 Mitotic kinesin inhibitors |
| 07/27/2005 | EP1556046A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
| 07/27/2005 | EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 07/27/2005 | EP1556029A2 Thiomolybdate analogues and uses thereof |
| 07/27/2005 | CN1646540A Functionalized ionic liquids, and methods of use thereof |
| 07/27/2005 | CN1646518A 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |